2016年世界卫生组织髓系增殖性肿瘤分类对临床有多大影响？ - Suppr

Suppr

超能文献

How much does 2016 WHO classification of myeloproliferative neoplasms affect the clinic?

作者信息

Cassinat Bruno, Giraudier Stephane, Kiladjian Jean-Jacques

机构信息

a APHP, Hopital Saint-Louis, Service de Biologie Cellulaire , Paris , France.

b Inserm UMRS-1131, IUH, Hopital Saint-Louis , Paris , France.

出版信息

Expert Rev Hematol. 2019 Jul;12(7):473-476. doi: 10.1080/17474086.2019.1623019. Epub 2019 Jun 4.

DOI:10.1080/17474086.2019.1623019

PMID:31161817

Abstract

摘要

相似文献

How much does 2016 WHO classification of myeloproliferative neoplasms affect the clinic?

Expert Rev Hematol. 2019 Jul;12(7):473-476. doi: 10.1080/17474086.2019.1623019. Epub 2019 Jun 4.

Blastic Plasmacytoid Dendritic Cell Neoplasm in 2020 and Beyond.

Hematol Oncol Clin North Am. 2020 Jun;34(3):xiii-xiv. doi: 10.1016/j.hoc.2020.02.011. Epub 2020 Mar 20.

Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients.

Hematol Oncol Clin North Am. 2020 Apr;34(2):475-489. doi: 10.1016/j.hoc.2019.11.001. Epub 2019 Dec 25.

The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances.

Blood Rev. 2016 Nov;30(6):453-459. doi: 10.1016/j.blre.2016.06.001. Epub 2016 Jun 11.

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies.

Hematol Oncol. 2020 Dec;38(5):654-664. doi: 10.1002/hon.2771. Epub 2020 Sep 4.

NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018.

J Natl Compr Canc Netw. 2017 Oct;15(10):1193-1207. doi: 10.6004/jnccn.2017.0157.

Myeloproliferative neoplasms: Morphology and clinical practice.

Am J Hematol. 2016 Jun;91(4):430-3. doi: 10.1002/ajh.24288.

The need for United States-based guidelines for myeloproliferative neoplasms.

J Natl Compr Canc Netw. 2015 May;13(5):607-9. doi: 10.6004/jnccn.2015.0078.

[Current diagnosis of myeloproliferative neoplasms (2008 WHO classification)].

Klin Lab Diagn. 2011 Jan(1):43-9.

Myeloproliferative syndrome in childhood.

Pediatr Pathol. 1983 Jul-Sep;1(3):311-8. doi: 10.3109/15513818309040668.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

How much does 2016 WHO classification of myeloproliferative neoplasms affect the clinic?

Expert Rev Hematol. 2019 Jul;12(7):473-476. doi: 10.1080/17474086.2019.1623019. Epub 2019 Jun 4.

Blastic Plasmacytoid Dendritic Cell Neoplasm in 2020 and Beyond.

Hematol Oncol Clin North Am. 2020 Jun;34(3):xiii-xiv. doi: 10.1016/j.hoc.2020.02.011. Epub 2020 Mar 20.

Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients.

Hematol Oncol Clin North Am. 2020 Apr;34(2):475-489. doi: 10.1016/j.hoc.2019.11.001. Epub 2019 Dec 25.

The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances.

Blood Rev. 2016 Nov;30(6):453-459. doi: 10.1016/j.blre.2016.06.001. Epub 2016 Jun 11.

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies.

Hematol Oncol. 2020 Dec;38(5):654-664. doi: 10.1002/hon.2771. Epub 2020 Sep 4.

NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018.

J Natl Compr Canc Netw. 2017 Oct;15(10):1193-1207. doi: 10.6004/jnccn.2017.0157.

Myeloproliferative neoplasms: Morphology and clinical practice.

Am J Hematol. 2016 Jun;91(4):430-3. doi: 10.1002/ajh.24288.

The need for United States-based guidelines for myeloproliferative neoplasms.

J Natl Compr Canc Netw. 2015 May;13(5):607-9. doi: 10.6004/jnccn.2015.0078.

[Current diagnosis of myeloproliferative neoplasms (2008 WHO classification)].

Klin Lab Diagn. 2011 Jan(1):43-9.

Myeloproliferative syndrome in childhood.

Pediatr Pathol. 1983 Jul-Sep;1(3):311-8. doi: 10.3109/15513818309040668.